Article | July 21, 2021

Direct-To-Patient Solutions: Technology To Help Improve Patient Recruitment And Retention

Source: YPrime

By Ryan Ridge, Senior Director, IRT Operations, YPrime

patient BYOD iStock-1127904439

Ongoing patient recruitment and retention challenges were intensified by the Covid-19 global pandemic. Adoption of alternative trial designs and technology solutions accelerated among clinical research professionals looking for ways to make it easier for patients to participate in clinical  trials, regardless of their location. One alternative trial design is the Direct-to-Patient (DtP) strategy, where study drug is shipped directly to the patient, and technology solutions play a critical role in managing the supply chain and ensuring that, at the end of the lifecycle, there is full accountability. This article explores what DtP is, as well as its benefits and complexities.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader